LakeShore Biopharma Co Total Revenue

LakeShore Biopharma Co (YS) currently reports a total revenue of $570M as of March 2024. That is below the sector sector average of $1.4B. Use the charts on this page to explore LakeShore Biopharma Co's total revenue history and peer comparisons.

LakeShore Biopharma Co's total revenue of $570M is lower than the its sector sector average of $1.4B. That is roughly 58.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

LakeShore Biopharma Co reported $570M in total revenue as of March 2024. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $570M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $1.4B. From there, open related valuation or income-statement pages for LakeShore Biopharma Co, and consider following YS for alerts when major investors trade the stock.